Roth Capital Factors In Centrus Energy (LEU)’s Long-Term Growth, Raises PT To $230

Why It Matters

The upgraded target and expanding backlog signal strong upside for investors as nuclear fuel demand rises with SMR deployment. Strategic partnerships and AI‑driven cost savings could improve margins and position Centrus as a key supplier in the next‑generation reactor market.

Key Takeaways

• Roth raised Centrus price target to $230, up 68% from $137.
• Centrus posted $76.7M revenue, 5% year‑over‑year growth.
• Adjusted net income $23.5M, or $1.05 per diluted share.
• $3.9B backlog runs through 2040, underpinning future earnings.
• Fluor, Palantir, Oklo collaborations target cost cuts and HALEU services.

Pulse Analysis

The global nuclear sector is entering a new phase as small‑modular reactors (SMRs) move from pilot projects to commercial rollout. Governments in the United States, Europe and Asia are allocating billions of dollars to diversify energy mixes and meet carbon‑reduction goals, creating a surge in demand for enriched uranium and related services. Centrus Energy Corp., a U.S. supplier of low‑enriched uranium (LEU) and fuel‑fabrication expertise, sits at the nexus of mining, conversion and reactor fuel supply, giving it a strategic foothold as the industry scales.

Centrus’ first‑quarter 2026 results reflect that strategic positioning. Revenue climbed 5% to $76.7 million, while adjusted earnings rose to $23.5 million, or $1.05 per diluted share, despite GAAP profit compression from a $15.9 million increase in advanced‑technology costs. More compelling is the $3.9 billion backlog that stretches to 2040, underpinning the company’s revenue guidance lift to $450‑$500 million for the full year. Roth Capital’s price‑target hike to $230— a 68% premium over the prior $137— signals confidence that the market is undervaluing these long‑term contracts.

Beyond the balance sheet, Centrus is accelerating operational efficiency through high‑profile collaborations. A joint effort with engineering giant Fluor bolsters plant expansion, while a partnership with Palantir leverages artificial‑intelligence analytics to target roughly $300 million in cost reductions. The exploratory joint venture with Oklo to provide HALEU de‑conversion services positions the firm in the emerging high‑assay low‑enriched uranium market, a critical fuel for next‑generation reactors. If these initiatives deliver, Centrus could improve margins and capture a larger share of the growing nuclear fuel supply chain, though execution risk and regulatory uncertainty remain.